Physician profile
Reginald L Baker
NPI 1942261631
$8,344.60
in general payments reported to CMS, 2019-2025
10 companies · $1,691 in 2025
The $1,691 reported for 2025 was more than what 95% of Diagnostic Ultrasound providers received nationally (typical 2025 total: $95.70).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,285 · 2020: $679 · 2021: $192 · 2022: $2,335 · 2023: $1,066 · 2024: $1,098 · 2025: $1,691.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,160 · Travel and Lodging: $989 · Consulting Fee: $705.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,160.40 |
| Travel and Lodging | $989.16 |
| Consulting Fee | $705.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,706.71 | 2020-2025 | Angiojet Ultra 5000a, Therasphere Y90 Glass Microspheres 10 Gbq, General - Pain Management |
| Penumbra, INC. | $2,428.49 | 2019-2025 | Indigo System |
| Angiodynamics, INC. | $910.01 | 2019 | |
| Microvention, INC. | $705.00 | 2024 | |
| Inari Medical, INC. | $683.39 | 2020-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Medtronic USA, INC. | $434.20 | 2020 | |
| Bard Peripheral Vascular, INC. | $127.29 | 2019 | |
| Janssen Products, LP | $120.77 | 2019 | |
| Medtronic, INC. | $114.56 | 2024 | Endurant Iis |
| Shockwave Medical, INC | $114.18 | 2024-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Reginald Baker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.